Literature DB >> 8692395

Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

R A Kroll1, M A Pagel, L L Muldoon, S Roman-Goldstein, E A Neuwelt.   

Abstract

The volume of distribution in tissue (Vt) that can be achieved by direct interstitial infusion of therapeutic agents into brain is limited. The maintenance of a pressure gradient during interstitial infusion to establish fluid convection has been shown to increase the Vt of small, medium, and large molecules. We have used monocrystalline iron oxide nanocompounds, superparamagnetic particles of sizes the same order of magnitude as virions, to investigate the effect of dose, the volume of infusate, and the time of infusion on the distribution of large molecules in rodent brain. Our initial study in rats (n = 6) replicated the results of a previously described report of convection-enhanced delivery in cats. At a constant rate and concentration, the Vt increased in a linear fashion, proportional to the increases in time, volume, and dose. When using a constant rate and a constant concentration, however, it is unclear which variable or variables (dose, volume, infusion time) have the greatest influence on this effect. Therefore, we assessed each variable independently (n = 12). When the iron dose was increased from 5.3 to 26.5 micrograms, there was a three- to fivefold increase in the Vt, depending on the volume and time of infusion (2 Microliters/20 min, 24 microliters/20 min, or 24 microliters/120 min) (P < 0.001). When the volume of infusate was increased from 2 to 24 microliters, at an infusion time of 20 minutes and a dose of either 5.3 or 26.5 micrograms, there was a 43 or 52% decline in the Vt, respectively (P = 0.018). When the time for the infusion of 24 microliters was increased from 20 to 120 minutes, there was a 79% increase in the Vt at a dose of 26.5 micrograms but no change in the Vt at a dose of 5.3 micrograms. The effect associated with infusion time was not significant (P = 0.113). Magnetic resonance imaging was performed to document the distribution of monocrystalline iron oxide nanocompounds in vivo, and histochemical staining for iron was used to document the distribution of monocrystalline iron oxide nanocompounds in tissue sections. The Vt for both methods was calculated by computer image analysis, and the correlation between magnetic resonance and histological volumes was determined (r2 = 0.93). On the basis of this model, we suggest that dose, rather than convection, might be the most important variable in maximizing the Vt and improved distribution might be achieved by administering an increased concentration of agent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692395

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  30 in total

1.  Allogeneic astrocytoma in immune competent dogs.

Authors:  M E Berens; A Giese; J R Shapiro; S W Coons
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Systemic temozolomide combined with loco-regional mitoxantrone in treating recurrent glioblastoma.

Authors:  A Boiardi; M Eoli; A Salmaggi; E Lamperti; A Botturi; G Broggi; L Bissola; G Finocchiaro; A Silvani
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents.

Authors:  Michal T Krauze; Ryuta Saito; Charles Noble; Matyas Tamas; John Bringas; John W Park; Mitchel S Berger; Krystof Bankiewicz
Journal:  J Neurosurg       Date:  2005-11       Impact factor: 5.115

4.  Strategies to enhance the distribution of nanotherapeutics in the brain.

Authors:  Clark Zhang; Panagiotis Mastorakos; Miguel Sobral; Sneha Berry; Eric Song; Elizabeth Nance; Charles G Eberhart; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2017-07-21       Impact factor: 9.776

5.  Novel contrast mixture improves bladder wall contrast for visualizing bladder injury.

Authors:  Pradeep Tyagi; Joseph J Janicki; T Kevin Hitchens; Lesley M Foley; Mahendra Kashyap; Naoki Yoshimura; Jonathan Kaufman
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-29

6.  Implementation of a chronic unilateral intraparenchymal drug delivery system in a swine model.

Authors:  Inyong Kim; Seungleal Paek; Brian D Nelson; Emily J Knight; Michael P Marsh; Allan J Bieber; Kevin E Bennet; Kendall H Lee
Journal:  J Neurosci Methods       Date:  2014-01-31       Impact factor: 2.390

7.  The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.

Authors:  Neal Luther; Zhiping Zhou; Pat Zanzonico; Nai-Kong Cheung; John Humm; Mark A Edgar; Mark M Souweidane
Journal:  Neuro Oncol       Date:  2014-02-12       Impact factor: 12.300

8.  Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.

Authors:  Jacob A Martin; Alexander S Maris; Moneeb Ehtesham; Robert J Singer
Journal:  J Vis Exp       Date:  2012-11-30       Impact factor: 1.355

9.  Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.

Authors:  Seunguk Oh; John R Ohlfest; Deborah A Todhunter; Vincent D Vallera; Walter A Hall; Hua Chen; Daniel A Vallera
Journal:  J Neurooncol       Date:  2009-06-11       Impact factor: 4.130

10.  Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates.

Authors:  Dali Yin; Francisco E Valles; Massimo S Fiandaca; John Bringas; Francisco Gimenez; Mitchel S Berger; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2009-09-15       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.